FGF-2 is a driving force for chromosomal instability and a stromal factor associated with adverse clinico-pathological features in prostate cancer - Pecqueux, Carine; Arslan, Aysenur; Heller, Martina; Falkenstein, Michael; Kaczorowski, Adam; Tolstov, Yanis; Sültmann, Holger; Grüllich, Carsten; Herpel, Esther; Hohenfellner, Markus; Duensing, Stefan (Urologic oncology, 2018)
Gesehen am 10.02.2020